Article Details

OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 ... - Morningstar

Retrieved on: 2024-02-22 13:17:50

Tags for this article:

Click the tags to see associated articles and topics

OncoC4 Announces First Patient with Advanced Prostate Cancer Dosed in Phase 1/2 ... - Morningstar. View article details on HISWAI: https://www.morningstar.com/news/globe-newswire/9041092/oncoc4-announces-first-patient-with-advanced-prostate-cancer-dosed-in-phase-12-trial-of-biontech-partnered-bnt316onc-392-program

Excerpt

BioNTech holds the exclusive worldwide commercialization rights for this product candidate. BNT316/ONC-392 is currently being evaluated in multiple ...

Article found on: www.morningstar.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up